Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review.
Pain Management · 2018-04-23 · Systematic review
Abstract
AIM: To assess the pharmacokinetic properties of community-use formulations of naloxone for emergency treatment of opioid overdose. METHODS: Systematic literature review based on searches of established databases and congress archives. RESULTS: Seven studies met inclusion criteria: two of US FDA-approved intramuscular (im.)/subcutaneous (sc.) auto-injectors, one of an FDA-approved intranasal spray, two of unapproved intranasal kits (syringe with atomizer attachment) and two of intranasal products in development. CONCLUSION: The pharmacokinetics of im./sc. auto-injector 2 mg and approved intranasal spray (2 and 4 mg) demonstrated rapid uptake and naloxone exposure exceeding that of the historic benchmark (0.4 mg im.), indicating that naloxone exposure was adequate for reversal of opioid overdose.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antidotes · Intranasal administration · Naloxone
Related articles
- American College of Medical Toxicology and the American Academy of Clinical Toxicology position statement: nalmefene should not replace naloxone as the primary opioid antidote at this time. (Clin Toxicol (Phila), 2023)
- The Effect of Overdose Education and Naloxone Distribution: An Umbrella Review of Systematic Reviews. (Am J Public Health, 2021)
- The Effect of Overdose Education and Naloxone Distribution: An Umbrella Review of Systematic Reviews. (Am J Public Health, 2021)
- Management of Suspected Opioid Overdose With Naloxone in Out-of-Hospital Settings: A Systematic Review. (Ann Intern Med, 2017)
- Naloxone without the needle - systematic review of candidate routes for non-injectable naloxone for opioid overdose reversal. (Drug Alcohol Depend, 2016)
- The RESPONDER trial: a feasibility study of an early intervention model deploying community first responders to administer intranasal naloxone in suspected opioid overdoses in Skåne, Sweden. (BMJ Open, 2026)